How has Acadia Pharmaceuticals's gain loss on sale of other assets changed year-over-year?

Acadia Pharmaceuticals's gain loss on sale of other assets decreased by 100.0% year-over-year, from $36.63M to $0.

Acadia Pharmaceuticals ACAD Gain Loss On Sale Of Other Assets

Gain Loss On Sale Of Other Assets at other companies

TFS FinancialTFSL

-$218K—

ItronITRI

$0+100%

Dime Community Bancshares DCOM

-$320K—

EAT

Brinker InternationalEAT

-$2.3M+8.0%

Six Flags EntertainmentFUN

$0+100%

APA CorporationAPA

$15M+122%

Segments

By segment

See full

Reportable Segment Aggregation Before Other Operating$0-100%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.87B+37.0%

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnSaleOfOtherAssets.

The official record: Acadia Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's gain loss on sale of other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's gain loss on sale of other assets?: Acadia Pharmaceuticals (ACAD) reported gain loss on sale of other assets of $0 in Q4 2025.
How has Acadia Pharmaceuticals's gain loss on sale of other assets changed year-over-year?: Acadia Pharmaceuticals's gain loss on sale of other assets decreased by 100.0% year-over-year, from $36.63M to $0.